ClinicalTrials.gg
RecruitingNCT07051772APPROCHEUpdated Jan 16, 2026

Predictive Factors for the Success of Rehabilitation Programs in Chronic Low Back Pain

An observational study in Low Back Pain, sponsored by Centre Hospitalier Universitaire de Nīmes. Recruiting at 6 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Observational

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
333
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes — 3 open to participants now, 3 under way, none of them phase 3. Low Back Pain · Centre Hospitalier Universitaire de Nīmes.

Started
2025
with 1 other
Observational
8 of 12
2 open now
Registered
11th of 12
by date

Among the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, this one is one of 2 that started in 2025, is one of 8 observational ones, and was the 11th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

3 of the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, or all of them as a file.
02

Study summary

Chronic low back pain is the leading cause of years lived with disability in the world among 19-49 year olds. The usual progression leads to 15% of acute episodes of persistent pain and more than 50% of persistent activity limitations. Persistent pain lasting between 5 and 7 years causes relatively stable patterns, probably linked to well-known predictive factors of activity limitations such as psychosocial factors (catastrophizing, fears and maladaptive beliefs), physical (deconditioning), professional (fear of returning to work, stress, burden) or personal (financial, insecurity). The effectiveness of treatments is often difficult to predict. Current evidence does not support the use of pharmacological treatments given their low effectiveness and the risks associated with the prescription of non-steroidal anti-inflammatories or opioids, particularly in the chronic phase where the risk of dependence is highest. Thus, international recommendations strongly suggest the use of non-pharmacological therapies, including, physical exercises, rehabilitation, physical and sports activities and spinal manipulations. Most meta-analyses conclude that there is a cumulative effect of the different strategies, without the specific effect of each one being able to be isolated, justifying multidisciplinary protocols. A cornerstone of the management of chronic disabling low back pain therefore relies programs combining physical, cognitive-behavioral, psychological and professional care, most often in dedicated centers. The objective is to empower the patient and promote a change in behavior with regard to the consequences of their pain in the long-term. However, there are very few predictive criteria for the success or failure of these programs, probably because many multiple biological, psychological, and social factors interact over time. Certain models resulting from expert consensus seek to conceptualize these interactions and propose a categorization of these different factors. It is now crucial to validate these categorizations and their relative weight in the progression of patients to best guide their recovery. The aim of this work is to identify the biomarkers predictive of the success of multidisciplinary programs in the short-, medium- and long-term.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Biomarkers
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of patients from the active consultation line in the Physical Medicine and Rehabilitation departments of the University Hospitals of Nîmes, Montpellier and Clermont-Ferrand for chronic low back pain.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient with chronic low back pain ≥ three months
  • The patient must have given their free and and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

Exclusion criteria

Exclusion Criteria:

  • The patient is participating in a category 1 interventional study, or a study on a medication or medical device without prior approval of the primary investigator
  • The patient is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient followed or treated for a psychiatric, cancerous or orthopedic pathology that risks modifying their course of care
  • Pregnant, parturient or breastfeeding patient.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
333 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients recruited from Nîmes center

    Other: mobility skills testing session

Interventions

  • Othermobility skills testing session

    A mobility skills testing session using the Qualisys system (Trinoma), when carrying out specific tasks plus 7-day recording of activity using an accelerometer.

06

What researchers measure

Primary outcomes

  1. Level of disability

    Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.

    Time frame: Baseline

  2. Level of disability

    Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.

    Time frame: Month 6

  3. Patient age

    Years

    Time frame: Baseline

  4. Patient sex

    Male/female

    Time frame: Baseline

  5. Patient Body Mass Index

    Kg/m2

    Time frame: Baseline

  6. Comorbidities

    List of medical pathologies and history of other pathologies of the musculoskeletal system (peripheral osteoarthritis, trauma to the musculoskeletal system, other musculoskeletal disorders).

    Time frame: Baseline

  7. Pain duration

    Months

    Time frame: Baseline

  8. Professional situation

    Description of profession

    Time frame: Baseline

  9. Work stoppage

    Yes/No

    Time frame: Baseline

  10. Work accident

    Yes/No

    Time frame: Baseline

  11. Disability

    Yes/No

    Time frame: Baseline

  12. Professional Life Satisfaction Scale Socio-economic level

    Time frame: Baseline

  13. Marital status

    Time frame: Baseline

  14. Number of children

    Number

    Time frame: Baseline

  15. Kinesiophobia

    Tampa scale

    Time frame: Baseline

  16. Coping strategies

    Coping Strategies Questionnaire

    Time frame: Baseline

  17. Avoidance Beliefs

    Fear-Avoidance Beliefs Questionnaire

    Time frame: Baseline

  18. Self-efficacy

    Pain Self-Efficacy Questionnaire

    Time frame: Baseline

  19. Catastrophism

    Pain Catastrophizing Scale

    Time frame: Baseline

  20. Acceptance

    Acceptance and Action Questionnaire

    Time frame: Baseline

  21. Anxiety and depression

    Hospital Anxiety and Depression Scale

    Time frame: Baseline

  22. Mobility

    Schöber test Finger-to-ground distance

    Time frame: Baseline

  23. Static endurance of the abdominal muscles

    Shirado test, seconds

    Time frame: Baseline

  24. Isometric endurance of hip and back extensor muscles

    Sorensen test, seconds

    Time frame: Baseline

  25. Central Sensitization

    Central Sensitization Inventory

    Time frame: Baseline

  26. Location of pain

    Patient-described using a body diagram

    Time frame: Baseline

  27. Number and severity of discopathies

    Pfirmann classification, measured on MRI

    Time frame: Baseline

  28. Modic changes on MRI

    Present/Absent

    Time frame: Baseline

  29. Narrow lumbar canal

    Yes/No, Measured on MRI

    Time frame: Baseline

  30. Postural disorder

    Yes/No

    Time frame: Baseline

  31. Scoliosis

    Cobb angle

    Time frame: Baseline

  32. Sagittal balance

    Measured using weight-bearing x-rays

    Time frame: Baseline

  33. Physical Activity

    International Physical Activity Questionnaire

    Time frame: Baseline

  34. Exercise Adherence Rating Scale Sleep

    Pittsburgh Questionnaire

    Time frame: Baseline

  35. Smoking

    Time frame: Baseline

  36. Alcohol consumption

    Time frame: Baseline

  37. Drug use

    Yes/No

    Time frame: Baseline

  38. Knowledge about low back pain

    Back Beliefs Questionnaire

    Time frame: Baseline

  39. Treatment pathway

    Description of previous physiotherapy treatments, infiltrations, osteopathy/manual therapy, medicinal treatments

    Time frame: Baseline

Secondary outcomes

  1. Level of disability

    Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.

    Time frame: Month 1

  2. Level of disability

    Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.

    Time frame: Month 3

  3. Level of disability

    Oswestry Disability Index questionnaire. Scoring: 0% to 20%: minimal disability, 20% to 40%: moderate disability, 40% to 60%: severe disability, 60% to 80%: major disability, and 80% to 100 %: bedridden or exaggerated.

    Time frame: Month 12

  4. Level of pain

    Visual Analog Scale, 0-100

    Time frame: Month 1

  5. Level of pain

    Visual Analog Scale, 0-100

    Time frame: Month 3

  6. Level of pain

    Visual Analog Scale, 0-100

    Time frame: Month 6

  7. Level of pain

    Visual Analog Scale, 0-100

    Time frame: Month 12

  8. Patient-reported health-related quality of life

    Quality of life questionnaire EQ-5D questionnaire, score 0-100

    Time frame: Baseline

  9. Patient-reported health-related quality of life

    EQ-5D questionnaire, score 0-100

    Time frame: Month 1

  10. Patient-reported health-related quality of life

    Quality of life questionnaire EQ-5D questionnaire, score 0-100

    Time frame: Month 3

  11. Patient-reported health-related quality of life

    EQ-5D questionnaire, score 0-100

    Time frame: Month 6

  12. Patient-reported health-related quality of life

    EQ-5D questionnaire, score 0-100

    Time frame: Month 12

  13. Return to work

    Number of days until return to work after end of physiotherapy program

    Time frame: Month 12

  14. Patients' feelings about symptoms

    PGI-C (Patient Global Impression of Change) questionnaire, score 1-7

    Time frame: Month 1

  15. Patients' feelings about symptoms

    PGI-C (Patient Global Impression of Change) questionnaire, score 1-7

    Time frame: Month 3

  16. Patients' feelings about symptoms

    PGI-C (Patient Global Impression of Change) questionnaire, score 1-7

    Time frame: Month 6

  17. Patients' feelings about symptoms

    PGI-C (Patient Global Impression of Change) questionnaire, score 1-7

    Time frame: Month 12

  18. Mobility abilities of willing patients recruited in the Nîmes center during walking

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Baseline

  19. Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Baseline

  20. Mobility abilities of willing patients recruited in the Nîmes center during drop jumps

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Baseline

  21. Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Baseline

  22. Mobility abilities of willing patients recruited in the Nîmes center during walking

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Month 3

  23. Mobility abilities of willing patients recruited in the Nîmes center during trunk lateral rotations

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Month 3

  24. Mobility abilities of willing patients recruited in the Nîmes center during drop jumps

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Month 3

  25. Mobility abilities of willing patients recruited in the Nîmes center during Star Excursion Balance Test

    Three-dimensional optokinetic analysis using Qualisys system

    Time frame: Month 3

  26. Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days

    Measured using an accelerometer (ActiGraph, GTX3), minutes

    Time frame: Baseline

  27. Moderate-to-vigorous physical activity level of willing patients recruited in the Nîmes center over 7 days

    Measured using an accelerometer (ActiGraph, GTX3), minutes

    Time frame: Month 3

  28. Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days

    Periods of walking \>10 seconds

    Time frame: Baseline

  29. Accelerometric parameters of willing patients recruited in the Nîmes center of walking over 7 days

    Periods of walking \>10 seconds

    Time frame: Month 3

  30. Number of steps of willing patients recruited in the Nîmes center over 7 days

    Number, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  31. Number of steps of willing patients recruited in the Nîmes center over 7 days

    Number, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  32. Duration of a walking period of willing patients recruited in the Nîmes center over 7 days

    Minutes, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  33. Duration of a walking period of willing patients recruited in the Nîmes center over 7 days

    Minutes, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  34. Walking speed of willing patients recruited in the Nîmes center

    Km/hour

    Time frame: Baseline

  35. Walking speed of willing patients recruited in the Nîmes center

    Km/hour

    Time frame: Month 3

  36. Length of strides of willing patients recruited in the Nîmes center

    Measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  37. Length of strides of willing patients recruited in the Nîmes center

    Measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  38. Duration of strides of willing patients recruited in the Nîmes center

    Measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  39. Duration of strides of willing patients recruited in the Nîmes center

    Measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  40. Frequency of strides

    Medio-lateral and antero-posterior, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  41. Frequency of strides

    Medio-lateral and antero-posterior, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  42. Acceleration of willing patients recruited in the Nîmes center

    Root mean square of the variability of the amplitude of acceleration, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  43. Acceleration of willing patients recruited in the Nîmes center

    Root mean square of the variability of the amplitude of acceleration, measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

  44. Gait regularity of willing patients recruited in the Nîmes center

    measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Baseline

  45. Gait regularity of willing patients recruited in the Nîmes center

    measured using an accelerometer (ActiGraph, GTX3)

    Time frame: Month 3

07

Study locations

1 of 6 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Feb 2028, 36 months after the start.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 36 months is above that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2025
First posted
Jul 4, 2025
StartActual
Feb 19, 2025
Primary completionEst.
Feb 2028
CompletionEst.
Aug 2028
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07051772
Responsible party
Sponsor
First posted
Jul 4, 2025
Start date
Feb 19, 2025
Primary completion
Feb 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Jan 16, 2026

Study contacts

Arnaud Dupeyron
Contact
arnaud.dupeyron@chu-nimes.fr
04.66.68.34.59
Arnaud Dupeyron
principal investigator · CHU de Nimes

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion